Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells

By Phuong Nguyen  

Breast Cancer Research and Treatment, Vol. 130, Iss. 1, 2011-11 ,pp. : 73-83

Springer Publishing Company

Access to resources Recommend Favorite

Differential effect of EGFR inhibitors on tamoxifen-resistant breast cancer cells

By          

Oncology Reports, Vol. 34, Iss. 3, 2015-01 ,pp. : 1613-1619

Spandidos Publications

Access to resources Recommend Favorite

Liarozole Fumarate (R85246): In the Treatment of ER Negative, Tamoxifen Refractory or Chemotherapy Resistant Postmenopausal Metastatic Breast Cancer

By Goss P.E.  

Breast Cancer Research and Treatment, Vol. 64, Iss. 2, 2000-11 ,pp. : 177-188

Springer Publishing Company

Access to resources Recommend Favorite

A phase III comparison of two toremifene doses to tamoxifen in postmenopausal women with advanced breast cancer

By Gershanovich M.  

Breast Cancer Research and Treatment, Vol. 45, Iss. 3, 1997-09 ,pp. : 251-262

Springer Publishing Company

Access to resources Recommend Favorite

High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment

By Kvinnsland S.   Anker G.   Dirix L.-Y.   Bonneterre J.   Prove A.-M.   Wilking N.   Lobelle J.-P.   Mariani O.   di Salle E.   Polli A.   Massimini G.  

European Journal of Cancer, Vol. 36, Iss. 8, 2000-05 ,pp. : 976-982

Elsevier

Access to resources Recommend Favorite